Clinical efficacy of oxidative stress correction by actovegin in diabetic polyneuropathy at type 2 diabetic patients with arterial hypertension
Aim. To study Actovegin efficacy in oxidative stress (OS) correction at diabetic polyneuropathy (DPN) in patients with diabetes mellitus type 2 (DM2)and arterial hypertension (AH).Materials and Methods. 51 patients (24 women and 27 men) aged 53.4?0.7 with the average duration of DM2 5.6?0.2 years,...
Main Authors: | Ivan Petrovich Gorshkov, Vladimir Ivanovich Zoloedov, Anna Petrovna Volynkina |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2010-06-01
|
Series: | Сахарный диабет |
Subjects: | |
Online Access: | https://www.dia-endojournals.ru/jour/article/view/5680 |
Similar Items
-
Diabetic polyneuropathy: efficacy of Actovegin
by: I. A. Strokov, et al.
Published: (2013-12-01) -
TREATMENT OF DIABETIC DISTAL POLYNEUROPATHY WITH ACTOVEGIN® IN TYPE 2 DIABETIC PATIENTS.
by: E. U. Komelyagina, et al.
Published: (2017-07-01) -
Diabetic polyneuropathy: effectiveness of therapy with Actovegin
by: O. A. Shavlovskaya
Published: (2014-12-01) -
ACTOVEGIN® IN THERAPY OF SUBCLINICAL DISTAL SYMMETRICAL SENSOR-MOTOR POLYNEUROPATHY IN 2ND TYPE DIABETES MELLITUS
by: A. S. FOKINA, et al.
Published: (2016-12-01) -
NEFROPROTECTIVE EFFECTS OF ACTOVEGIN IN PATIENTS WITH DIABETIC NEPHROPATHY
by: І.І. Topchii, et al.
Published: (2017-12-01)